UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents

Scientific reports, 2019-12, Vol.9 (1), p.18045-15, Article 18045

2019

Volltextzugriff (PDF)

The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents

Scientific reports, 2018-02, Vol.8 (1), p.2416-25, Article 2416

2018

Volltextzugriff (PDF)

Confirmation of antidepressant potential of the selective β3 adrenoceptor agonist amibegron in an animal model of depression

Pharmacology, biochemistry and behavior, 2008-06, Vol.89 (4), p.623-626

2008

Volltextzugriff (PDF)

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Neuropsychopharmacology (New York, N.Y.), 2007-04, Vol.33 (3), p.574-587

2007

Volltextzugriff (PDF)

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Current pharmaceutical design, 2005-05, Vol.11 (12), p.1549-1559

2005

Volltextzugriff (PDF)

Disruption of the Prepulse Inhibition of the Startle Reflex in Vasopressin V1b Receptor Knockout Mice: Reversal by Antipsychotic Drugs

Neuropsychopharmacology (New York, N.Y.), 2005-11, Vol.30 (11), p.1996-2005

2005

Volltextzugriff (PDF)

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

Biological psychiatry (1969), 2005-02, Vol.57 (3), p.261-267

2005

Volltextzugriff (PDF)

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2007-01, Vol.32 (1), p.17-34

2007

Volltextzugriff (PDF)

Alzheimer’s Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer’s Disease Patients

Journal of Alzheimer's disease, 2016-11, Vol.55 (1), p.321-331

2016

Volltextzugriff (PDF)

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415

Neuropsychopharmacology (New York, N.Y.), 2005-01, Vol.30 (1), p.35-42

2005

Volltextzugriff (PDF)

Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats

Synapse (New York, N.Y.), 2003-12, Vol.50 (3), p.171-180

2003

Volltextzugriff (PDF)

Confirmation of antidepressant potential of the selective beta 3 adrenoceptor agonist amibegron in an animal model of depression

Pharmacology, biochemistry and behavior, 2008-06, Vol.89 (4), p.623-626

2008

Volltextzugriff (PDF)

Implication of β3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress

Behavioural brain research, 2010-01, Vol.206 (2), p.310-312

2010

Volltextzugriff (PDF)

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Pharmacology, biochemistry and behavior, 2008-11, Vol.91 (1), p.47-58

2008

Volltextzugriff (PDF)

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models

Pharmacology, biochemistry and behavior, 2008-03, Vol.89 (1), p.36-45

2008

Volltextzugriff (PDF)

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

Psychopharmacologia, 2011-05, Vol.215 (1), p.149-163

2011

Volltextzugriff (PDF)

Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression

Pharmacology, biochemistry and behavior, 2008-06, Vol.89 (4), p.623-626

2008

Volltextzugriff (PDF)

Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients

Journal of Alzheimer's disease, 2017, Vol.55 (1), p.321

2017

Volltextzugriff (PDF)

SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy

Alzheimer's & dementia : translational research & clinical interventions, 2016-11, Vol.2 (4), p.267-280

2016

Volltextzugriff (PDF)

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin VIb receptor antagonist, SSR149415

Neuropsychopharmacology (New York, N.Y.), 2005, Vol.30 (1), p.35-42

2005

Volltextzugriff (PDF)

Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress

Behavioural brain research, 2010-01, Vol.206 (2), p.310-312

2010

Volltextzugriff (PDF)

Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment

Behavioural brain research, 1998-12, Vol.98 (1), p.53-66

1998

Volltextzugriff (PDF)

Stimulation of the [beta]3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Neuropsychopharmacology (New York, N.Y.), 2008-02, Vol.33 (3), p.574

2008

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Animals
(20)
Rats
(16)
Biological And Medical Sciences
(14)
Male
(14)
Science & Technology
(13)
Behavior, Animal - Drug Effects
(12)
Mice
(12)
Life Sciences & Biomedicine
(11)
Medical Sciences
(11)
Neurosciences
(11)
Neurosciences & Neurology
(11)
Psychology. Psychoanalysis. Psychiatry
(11)
Female
(10)
Pharmacology. Drug Treatments
(9)
Psychopharmacology
(9)
Anxiety
(8)
Neuropharmacology
(8)
Schizophrenia
(8)
Adult And Adolescent Clinical Studies
(7)
Psychopathology. Psychiatry
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer’s disease in rodents

The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Confirmation of antidepressant potential of the selective β3 adrenoceptor agonist amibegron in an animal model of depression

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders

Disruption of the Prepulse Inhibition of the Startle Reflex in Vasopressin V1b Receptor Knockout Mice: Reversal by Antipsychotic Drugs

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Alzheimer’s Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer’s Disease Patients

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415

Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats

Confirmation of antidepressant potential of the selective beta 3 adrenoceptor agonist amibegron in an animal model of depression

Implication of β3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models

AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents

Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression

Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients

SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin VIb receptor antagonist, SSR149415

Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress

Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment

Stimulation of the [beta]3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Suchergebnisse filtern